Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder AnalysisDRUG SAFETYIF3.82022-08-2511OAAI
Exploring sociodemographic and economic factors that promote adverse drug reactions reporting by patientsHEALTH POLICYIF3.42018-03-0113PREAI
Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European UnionPUBLIC HEALTHIF3.22018-02-017PREAI
The value of patient reporting to the pharmacovigilance system: a systematic reviewBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32016-10-12160OAAI
Language does not come in boxes: Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European PortugueseRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82015-09-016PREAI
Adverse Drug Reactions Spontaneous Reporting and MedDRA® Lingos: How Discrepant Are They in European Portuguese?RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82014-09-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向